Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation

Clinical Laboratory

Volumn 58, Issue 1-2, 2012, Pages 41-51

  Dong, Shang Wen ^a   Cui, Yuan Tao ^a   Zhong, Rong Rong ^a   Liang, Dong Chun ^a   Liu, Yi Mei ^a   Wang, Yuan Guo ^a   He, Zhun ^a   Wang, Shuo ^a   Liang, Shao Jie ^a   Zhang, Peng ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

5 aza 2 deoxycytidine; ESCC; MSP; Promoter methylation; RIZ1; TSG

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE; RETINOBLASTOMA PROTEIN; ZINC FINGER PROTEIN;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN INTERACTING ZINC FINGER GENE 1 GENE;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; DNA-BINDING PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84863175288     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Enzinger PC, Mayer RJ. Esophageal cancer. The New England Journal of Medicine 2003;349(23):2241-52. (Pubitemid 37485141)
2. Chen BS, Wang MR, Xu X, et al. Transglutaminase-3, an esophageal cancer-related gene. International Journal of Cancer 2000;88(6):862-5.
3. Metzger R, Schneider PM, Warnecke-Eberz U, Brabender J, Holscher AH. Molecular Biology of Esophageal Cancer. Onkologie 2004;27(2):200-6. (Pubitemid 38621614)
4. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogennesis: A review. International Journal of Cancer 1996;69(3):225-35. (Pubitemid 26233303)
5. Qin YR, Wang LD, Fan ZM, Kwong D, Guan XY. Comparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China. World J Gastroenterol 2008;14(12):1828-35. (Pubitemid 351523811)
6. Kass SU, Pruss D, Wolffe AP. How does DNA methylation repress transcription? Trends Genet 1997;13:444-9. (Pubitemid 27479903)
7. Razin A, Ceder H. DNA methylation and gene expression. Microbiol Rev 1991;55:451-8'.
8. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7. (Pubitemid 29070360)
9. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9. (Pubitemid 32695003)
10. Liu L, Shao G, Steel-Perkins G, Huang S. The retinoblastoma interacting zinc finger gene RIZ produces a PR domain lacking product through an internal promoter. J Biol Chem 1997;272:2984-91. (Pubitemid 27053351)
11. Steele-Perkins G, Fang W, Yang XH, et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein- methyltransferase superfamily. Genes Dev 2001; 15: 2250-62. (Pubitemid 32843837)
12. He L, Yu JX, Liu L, et al. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 1998;58:4238-44. (Pubitemid 28450017)
13. Hasegawa Y, Matsubara A, Teishima J, et al. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Cancer Sci 2007;98:32-6. (Pubitemid 44803917)
14. Lal G, Padmanabha L, Smith BJ, et al. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer 2006;107:2752-9. (Pubitemid 44937027)
15. Patrizia Gazzerro, Ciro Abbondanza, Andrea D'Arcangelo, et al. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Experimental Cell Research 2006;312:340-9.
16. Tokumaru Y, Nomoto S, Jeronimo C, et al. Biallelic inactivation of the RIZ1 gene in human gastric cancer. Oncogene 2003;22,6954-8. (Pubitemid 37386697)
17. Fang W, Piao Z, Buyse IM, et al. Preferential loss of a polymerphic RIZ allele in human hepatocellular carcinoma. British Journal of Cancer 2001;84(6):743-47. (Pubitemid 32275645)
18. Kamb A, Gruis N A, Weavev-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264(5157):436-40.
19. Du Y, Carting T, Fang W, Piao Z, Sheu JC, Huang S. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 2001;61:8094-99. (Pubitemid 33091596)
20. Hasegawa Y, Matsubara A, Teishima J, et al. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Cancer Sci 2007; 98:32-6. (Pubitemid 44803917)
21. Oshimo Y, Oue N, Mitani Y, et al. Frequent epigenetic inactivetion of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer 2004;110:212-8. (Pubitemid 38580393)
22. Lal G, Padmanabha L, Smith BJ, et al. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer 2006;107:2752-9. (Pubitemid 44937027)
23. Fang W, Piao Z, Simon D, Sheu J-C, Huang S. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ(PRDM2) gene localized to the region. Genes Chromosomes Cancer 2000;28:269-75. (Pubitemid 30399556)
24. Fang W, Piao Z, Simon D, Sheu J-C, Perucho M, Huang S. Preferential loss in human cancer of polymorphic RIZ allele that is more common in Asians than Caucasians. Br J Cancer 2001;84:743-7. (Pubitemid 32275645)